NovoCure Ltd — Director's Dealing 2023

Jan 10, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-01-05

Reporting Person: Weinberg Uri (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-05	Ordinary Shares	S	2379	$120	Disposed	47104	Direct
2023-01-05	Ordinary Shares	M	1946	$47.04	Acquired	49050	Direct
2023-01-05	Ordinary Shares	S	1946	$120	Disposed	47104	Direct
2023-01-05	Ordinary Shares	S	2617	$108	Disposed	44487	Direct
2023-01-05	Ordinary Shares	S	1201	$120	Disposed	43286	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-05	Options to Buy Ordinary Shares	$47.04	M	1946	Disposed	2029-03-21	Ordinary Shares (1946.0)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg.

F2: Fully vested as of the date hereof.